RISE Intervention to Reduce Sedentary Time and Prevent Cardiovascular Events in People After First Stroke

What this Trial Is About

Researchers are evaluating the effectiveness of the RISE blended behavioral intervention in people who have had a first stroke. The study aims to prevent major adverse cardiovascular events such as recurrent stroke, transient ischemic attack TIA, acute coronary events, and cardiovascular death over a one-year follow-up, compared to standard care. The study also examines the cost-effectiveness of the intervention and its impact on reducing sedentary behavior in community-dwelling stroke survivors with sedentary movement patterns. Participants are randomly assigned to either the experimental group receiving the 15-week RISE intervention alongside usual care or the control group receiving usual care only. The RISE intervention involves coaching by a primary care physiotherapist using behavior change techniques and the RISE eCoaching system, which includes an activity monitor, smartphone app with real-time feedback and e-learning modules, and a monitoring dashboard for the physiotherapist. Participants also receive support from someone in their social network. Usual care follows hospital-specific guidelines. Participants will be involved in baseline, post-treatment four months, and follow-up assessments at six, nine, and twelve months after randomization. These include wearing an activity monitor, completing questionnaires, and performing physical tests. Researchers measure major adverse cardiovascular events, 24-hour activity patterns including sedentary behavior, physical activity, and sleep, as well as cost-effectiveness, quality of life, healthcare utilization, and productivity losses. The study is designed to minimize burden with home or online sessions and non-invasive assessments, lasting approximately 3.5 hours per measurement period.

Effectiveness of the RISE Intervention